Parker to Announce Fiscal 2021 Fourth Quarter and Full Year Earnings on August 5th; Conference Call and Webcast Scheduled for 11 a.m. Eastern
- Dow, S&P 500 end with gains up after bumpy week, but Nike drags
- Over $100 Billion Wiped Off: Bitcoin (BTC) Price Falls As China's Central Bank Vows to Ban Cryptocurrency Trading
- Nike (NKE) Stock Falls On a Revenue Miss and Slashed FY Sales Outlook, Analysts Bullish Despite NT Supply Chain Challenges
- Oil hits highest in almost 3 years as supply tightens
- Here's Why Meredith (MDP) Stock Price Soared 18% in After Hours
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
CLEVELAND, July 26, 2021 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it will release its fiscal 2021 fourth quarter and full year earnings before the market opens on Thursday, August 5, 2021, followed by a conference call at 11:00 a.m., Eastern time. During the call, the company will discuss fiscal 2021 fourth quarter and full year results and respond to questions from institutional investors and security analysts. The conference call will be webcast simultaneously on Parker's investor information website at www.phstock.com with an accompanying slide presentation. The webcast will be archived on the site and available for replay later that day.
Parker Hannifin is a Fortune 250 global leader in motion and control technologies. For more than a century the company has been enabling engineering breakthroughs that lead to a better tomorrow. Parker has increased its annual dividend per share paid to shareholders for 65 consecutive fiscal years, among the top five longest-running dividend-increase records in the S&P 500 index. Learn more at www.parker.com or @parkerhannifin.
Contact: Media – Aidan Gormley, Director, Global Communications and Branding 216/896-3258 firstname.lastname@example.org Financial Analysts – Robin J. Davenport, Vice President, Corporate Finance 216/896-2265 email@example.com
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kvika banki hf.: Transaction in relation to a share buyback programme
- GenScript ProBio and AskGene Enter into a Non-exclusive License of A sdAb Targeting Immune Checkpoint Target
- JW Therapeutics Announces Updated 1-year Follow-up Result of Relmacabtagene Autoleucel Injection At the 24th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO)
Create E-mail Alert Related CategoriesGlobe Newswire, Press Releases
Related EntitiesDavenport, Dividend, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!